Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

R J Murray, Michael G. Kurilla, Jill Brooks, +4

The Journal of Experimental Medicine

Target AntigensImmunologyAntigen ProcessingCd4 T Cell ResponsesImmune System +19

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

Rajiv Khanna, Scott R. Burrows, Michael G. Kurilla, +5

The Journal of Experimental Medicine

VaccinationTarget EpitopesUbiquitous Epstein-barr VirusVaccine DevelopmentVaccine Research +12

Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation

Blake Tomkinson, Erle S. Robertson, E Kieff

Journal of Virology

Viral ReplicationImmunologyPathologyImmunotherapyCancer-associated Virus +15

Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors

Mark Birkenbach, Knud Josefsen, Ramana R. Yalamanchili, +2

Journal of Virology

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

Victor Argaet, Christopher Schmidt, Scott R. Burrows, +8

The Journal of Experimental Medicine

Persistent InfectionSystems BiologyEpstein-barr VirusNeurovirologyMemory Response +13

An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.

Cathy L. Miller, J H Lee, E Kieff, +1

Proceedings of the National Academy of Sciences

Viral ReplicationViral PathogenesisImmunologyPathologyImmunotherapy +15

Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro.

Sankar Swaminathan, Blake Tomkinson, E Kieff

Proceedings of the National Academy of Sciences

Viral ReplicationGeneticsImmunologyPathologyRecombinant Epstein-barr Virus +16

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.

Kathleen Hennessy, Susan M. Fennewald, Mary Hummel, +2

Proceedings of the National Academy of Sciences

Dna Repeat ElementMolecular VirologyEpstein-barr VirusPathogenesisViral Pathogenesis +13

Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins

Martin Rowe, Lawrence S. Young, Karen A. Cadwallader, +3

Journal of Virology

Cancer-associated VirusMolecular VirologyType BEpstein-barr VirusPathogenesis +11

Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation

William E. Miller, George Mosialos, E Kieff, +1

Journal of Virology

ImmunologyPathologyImmunotherapyTumor BiologyCancer-associated Virus +14